0001214659-24-010004.txt : 20240528
0001214659-24-010004.hdr.sgml : 20240528
20240528115751
ACCESSION NUMBER: 0001214659-24-010004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wasoff Evan L
CENTRAL INDEX KEY: 0001719738
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55320
FILM NUMBER: 24988488
MAIL ADDRESS:
STREET 1: 101 WINGER DRIVE
CITY: NEDERLAND
STATE: CO
ZIP: 80466
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXIEN BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001625288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 262049376
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 4340 E KENTUCKY AVE
STREET 2: SUITE 206
CITY: GLENDALE
STATE: CO
ZIP: 80246
BUSINESS PHONE: 3034957583
MAIL ADDRESS:
STREET 1: 4340 E KENTUCKY AVE
STREET 2: SUITE 206
CITY: GLENDALE
STATE: CO
ZIP: 80246
FORMER COMPANY:
FORMER CONFORMED NAME: Intiva BioPharma Inc.
DATE OF NAME CHANGE: 20171129
FORMER COMPANY:
FORMER CONFORMED NAME: Kinder Holding Corp.
DATE OF NAME CHANGE: 20141114
4
1
marketforms-66041.xml
PRIMARY DOCUMENT
X0508
4
2024-05-23
0001625288
NEXIEN BIOPHARMA, INC.
NXEN
0001719738
Wasoff Evan L
4340 E KENTUCKY AVE
SUITE 206
GLENDALE
CO
80246
false
true
false
false
Chief Financial Officer
0
Common stock
2024-05-23
4
A
false
2000000
A
6500000
D
Options to purchase common stock (right to buy)
0.08
2020-08-19
2027-08-19
common stock
1500000
1500000
D
Options to purchase common stock (right to buy)
0.54
2018-07-25
2025-07-25
common stock
420000
420000
D
Options to purchase common stock (right to buy)
0.655
2018-10-26
2025-10-26
common stock
200000
200000
D
Issued in lieu of compensation for services.
Evan L. Wasoff
2024-05-28